US Patent Issued to BIOVIVA USA on March 3 for "Treatment of age-related cognitive decline using genetically modified viral vectors" (Washington, Louisiana, Alabama Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,646, issued on March 3, was assigned to BIOVIVA USA INC. (Bainbridge Island, Wash.).

"Treatment of age-related cognitive decline using genetically modified viral vectors" was invented by Elizabeth Louise Parrish (Bainbridge Island, Wash.), Patrick Ellison Sewell (Elm Grove, La.) and Jason R. Williams (Foley, Ala.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for treating or prophylactically treating age-related cognitive decline associated with dementia by administering recombinant viral vectors designed to deliver TERT and/or KL (Klotho) genes to the patient. The TERT and/or KL genes are packaged within one or more AAV...